Completed PHASE2 INTERVENTIONAL 2-arm NCT05027581

Chondrochymal® for Subjects With Knee Osteoarthritis (Knee OA)

A Phase IIb Study to Evaluate the Efficacy and Safety of Chondrochymal® for Subjects With Knee Osteoarthritis (Knee OA)

Sponsor: A2 Healthcare Taiwan Corporation

Interventions Bone marrow mesenchymal stem cells hyaluronic acid

Updated 8 times since 2021 Last updated: Jul 3, 2025 Started: Oct 13, 2021 Primary completion: Dec 10, 2023 Completion: Jun 4, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Osteoarthritis, Knee, this trial is completed. The trial is conducted by A2 Healthcare Taiwan Corporation and has accumulated 8 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

8 versions recorded

Aug 2025 — Present [monthly]

Completed PHASE2

Status: Active Not Recruiting → Completed
Dec 2024 — Aug 2025 [monthly]

Active Not Recruiting PHASE2
Sep 2024 — Dec 2024 [monthly]

Active Not Recruiting PHASE2
Aug 2024 — Sep 2024 [monthly]

Active Not Recruiting PHASE2
Jul 2024 — Aug 2024 [monthly]

Active Not Recruiting PHASE2

▶ Show 3 earlier versions

Mar 2024 — Jul 2024 [monthly]

Active Not Recruiting PHASE2

Status: Recruiting → Active Not Recruiting
Oct 2021 — Mar 2024 [monthly]

Recruiting PHASE2

Status: Not Yet Recruiting → Recruiting
Sep 2021 — Oct 2021 [monthly]

Not Yet Recruiting PHASE2

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

A2 Healthcare Taiwan Corporation
Taiwan Bio Therapeutics Inc.

Data source: Taiwan Bio Therapeutics Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Taipei, Taiwan